Siemens Biomarker Multi-modality

Recruiting now · Not applicable

Conditions studied: Fatty Liver, Hepatic Steatosis

In brief

The purpose of this study is to see how well Photon Counting CT (PCCT) and ultrasound test results can find fat and scarring in the liver. They will be compared to MRI test results as the reference standard. Participants will get a regular CT scan on the PCCT scanner, plus a few extra pictures just for the study. They will also get an MRI, either on the same day or a different day, whichever is preferred. Participants will get an ultrasound on the same day as the MRI. If they have not had a hematocrit blood test in the past 24 hours, they will also receive one on the day of the CT scan.

Key facts

Study ID

NCT07495332

Run by

Duke University

People needed

45

Starts

2026-03-27

Expected to finish

2027-05-01

Last updated by the study team

2026-04-03

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age of 18 years or older
• Has clinically indicated CT schedule including the liver (with contrast or with and without contrast)
• Patient eligible for MR imaging
• History of chronic diffuse liver disease, steatotic liver disease, and/ or liver fibrosis
• Capable of consent

You may not qualify if…

• Contraindications to any of the required imaging examinations
• BMI > 45 (based on MRI scanner capacity)

Where it is running

• Duke University Medical Center — Durham, North Carolina, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.